首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Discover oncology

缩写:

ISSN:N/A

e-ISSN:2730-6011

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4657
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Chengcheng Guo,Qunying Yang,Meiling Deng et al. Chengcheng Guo et al.
Purpose: Unmethylated MGMT is a validated biomarker for temozolomide (TMZ) resistance and poor prognosis in glioblastoma. VAL-083 (dianhydrogalactitol; DAG) is a DNA-targeting agent that forms interstrand crosslinks at O6...
Lingqin Ni,Luqi Li,De Li et al. Lingqin Ni et al.
Background: The purpose of this study was to establish a dosimetric correlation between the bladder filling volume and its effects on the dose received by the organs at risk (OARs) (bladder, rectum, sigmoid colon and smal...
Omar Arafah,Marihame Ashraf,Ahmed Mustafa Abd Elsalam et al. Omar Arafah et al.
Background: Improved treatment of childhood acute lymphoblastic leukemia (ALL) depends on the identification of new molecular markers that can predict treatment response and clinical outcome. Examination of the expression...
Yixuan Ding,Shiwei Cai,Jinzhou Cai et al. Yixuan Ding et al.
ORC1 is a core protein governing DNA replication initiation and cell cycle regulation, exhibiting significant overexpression in multiple malignancies where it correlates with advanced disease stage and poor prognosis. It drives tumor progre...
Yu Xu,Yanfu Bai,Fan Yang et al. Yu Xu et al.
Osteosarcoma (OS), the most common malignant bone tumor in adolescents, exhibits marked genetic and cellular heterogeneity, contributing to its resistance to conventional therapies. Although surgical and chemotherapeutic interventions have ...
Xingya Wang,Huichao Li,Xianzhen Wu Xingya Wang
Background: MicroRNAs (miRNAs) exert a crucial role in the progression of lung cancer (LC) and can serve as prognostic biomarkers. Aim: ...
Kai Yang,Jiatong Zhou Kai Yang
With the advancement of medical technology and improvements in living standards, the survival time of many cancer patients has been prolonged. However, a significant proportion of these patients develop multiple primary cancers (MPC), which...
Sama I Sayin,Ella A Eklund,Moa Beischer et al. Sama I Sayin et al.
Background: Brain metastases (BM) are a major clinical challenge in metastatic lung adenocarcinoma (LUAD), affecting up to 50% of patients during disease progression. Current guidelines do not mandate brain imaging for al...